G.F.C Green Fields Capital Resultados de beneficios anteriores
Pasado controles de criterios 3/6
G.F.C Green Fields Capital has been growing earnings at an average annual rate of 40.5%, while the Biotechs industry saw earnings growing at 10.5% annually.
Información clave
40.5%
Tasa de crecimiento de los beneficios
40.8%
Tasa de crecimiento del BPA
| Crecimiento de la industria Biotechs | -24.5% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera | 12.6% |
| Margen neto | n/a |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
No hay actualizaciones
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero G.F.C Green Fields Capital. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 0 | 21 | 1 | 0 |
| 31 Mar 24 | 0 | 19 | 1 | 0 |
| 31 Dec 23 | 0 | 16 | 1 | 0 |
| 30 Sep 23 | 0 | 9 | 1 | 0 |
| 30 Jun 23 | 0 | 2 | 1 | 0 |
| 31 Mar 23 | 0 | 0 | 1 | 0 |
| 31 Dec 22 | 0 | -2 | 1 | 0 |
| 30 Sep 22 | 0 | 1 | 1 | 0 |
| 30 Jun 22 | 0 | 3 | 1 | 0 |
| 31 Mar 22 | 0 | 6 | 1 | 0 |
| 31 Dec 21 | 0 | 8 | 1 | 0 |
| 30 Sep 21 | 0 | 10 | 1 | 0 |
| 30 Jun 21 | 0 | 11 | 1 | 0 |
| 31 Mar 21 | 0 | 5 | 1 | 0 |
| 31 Dec 20 | 0 | -1 | 1 | 0 |
| 30 Sep 20 | 0 | -2 | 1 | 0 |
| 30 Jun 20 | 0 | -4 | 1 | 0 |
| 31 Mar 20 | 0 | 0 | 1 | 0 |
| 31 Dec 19 | 0 | 4 | 1 | 0 |
| 30 Sep 19 | 0 | 3 | 1 | 0 |
| 30 Jun 19 | 0 | 2 | 1 | 0 |
| 31 Mar 19 | 0 | 2 | 1 | 0 |
| 31 Dec 18 | 0 | 2 | 1 | 0 |
| 30 Sep 18 | 0 | 4 | 1 | 0 |
| 30 Jun 18 | 0 | 5 | 1 | 0 |
| 31 Mar 18 | 0 | 4 | 1 | 0 |
| 31 Dec 17 | 0 | 4 | 1 | 0 |
| 30 Sep 17 | 0 | 6 | 1 | 0 |
| 30 Jun 17 | 0 | 7 | 1 | 0 |
| 31 Mar 17 | 0 | 11 | 1 | 0 |
| 31 Dec 16 | 0 | 12 | 1 | 0 |
| 30 Sep 16 | 0 | 10 | 2 | 0 |
| 30 Jun 16 | 0 | 12 | 1 | 0 |
| 31 Mar 16 | 0 | 8 | 2 | 0 |
| 31 Dec 15 | 0 | 11 | 2 | 0 |
| 30 Sep 15 | 0 | 12 | 3 | 0 |
| 30 Jun 15 | 0 | 12 | 3 | 0 |
| 31 Mar 15 | 0 | 12 | 3 | 0 |
| 31 Dec 14 | 0 | 8 | 1 | 0 |
| 30 Sep 14 | 0 | 9 | 2 | 0 |
| 30 Jun 14 | 0 | 0 | 3 | 0 |
| 31 Mar 14 | 0 | -2 | 3 | 0 |
Ingresos de calidad: GFC-M has a large one-off gain of ₪17.4M impacting its last 12 months of financial results to 30th June, 2024.
Margen de beneficios creciente: Insufficient data to determine if GFC-M's profit margins have improved over the past year.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: GFC-M's earnings have grown significantly by 40.5% per year over the past 5 years.
Acelerando crecimiento: GFC-M's earnings growth over the past year (1192.2%) exceeds its 5-year average (40.5% per year).
Beneficios vs. Industria: GFC-M earnings growth over the past year (1192.2%) exceeded the Biotechs industry 5.5%.
Rentabilidad financiera
Alta ROE: GFC-M's Return on Equity (12.6%) is considered low.